Deborah N Kalkman Selected Research

Insulin (Novolin)

1/2021	Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
1/2020	1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
10/2018	1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
1/2017	One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deborah N Kalkman Research Topics

Disease

17	Thrombosis (Thrombus) 01/2021 - 01/2016
6	Diabetes Mellitus 02/2022 - 01/2017
6	Death (Near-Death Experience) 12/2020 - 04/2018
5	Acute Coronary Syndrome 01/2021 - 08/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 10/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 06/2018
3	Myocardial Infarction 01/2019 - 04/2018
2	Stroke (Strokes) 02/2022 - 01/2019
2	Hemorrhage 12/2020 - 01/2020
2	Chronic Renal Insufficiency 12/2020 - 09/2020
2	Inflammation (Inflammations) 01/2019 - 12/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2018 - 04/2018
1	Atherosclerotic Plaque (Atheroma) 05/2024
1	Chest Pain (Chest Pains) 04/2024
1	Pheochromocytoma 04/2024
1	Cardiomyopathies (Cardiomyopathy) 04/2024
1	Spasm (Spasms) 04/2024
1	Left Ventricular Dysfunction 04/2024
1	Migraine Disorders (Migraine) 01/2023
1	Ischemic Stroke 02/2022
1	Rhabdomyolysis 02/2022
1	Hypersensitivity (Allergy) 01/2021
1	Injection Site Reaction 01/2021
1	Anemia 12/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Obesity 01/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2019
1	Atrial Fibrillation 12/2018
1	Wounds and Injuries (Trauma) 02/2018
1	Coronary Restenosis 01/2018
1	Stable Angina 08/2017
1	Neointima 01/2016
1	Pathologic Constriction (Stenosis) 10/2013

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2021 - 01/2017
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020 - 04/2018
2	alirocumabIBA 02/2022 - 01/2021
2	evolocumabIBA 02/2022 - 01/2021
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2016
2	C-Reactive ProteinIBA 01/2019 - 12/2018
1	MicroplasticsIBA 05/2024
1	TroponinIBA 04/2024
1	CalciumIBA 04/2024
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 04/2024
1	CatecholaminesIBA 04/2024
1	Calcitonin Gene-Related PeptideIBA 01/2023
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	Antidepressive Agents (Antidepressants)IBA 01/2023
1	Tryptamines (Triptans)IBA 01/2023
1	Angiotensin Receptor AntagonistsIBA 01/2023
1	PCSK9 InhibitorsIBA 02/2022
1	Proprotein Convertase 9IBA 02/2022
1	EnzymesIBA 02/2022
1	PolymersIBA 01/2021
1	erucylphosphocholineIBA 01/2021
1	CholesterolIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2018
1	Antihypertensive Agents (Antihypertensives)IBA 10/2018
1	Phenobarbital (Luminal)FDA Link 01/2016

Therapy/Procedure

19	Stents 01/2021 - 01/2016
5	Therapeutics 01/2023 - 06/2018
5	Percutaneous Coronary Intervention 09/2020 - 08/2017
2	Transcatheter Aortic Valve Replacement 01/2019 - 12/2018
1	Contraindications 01/2023
1	Drug-Eluting Stents 01/2016
1	Arterial Switch Operation 10/2013